Broadly neutralizing HIV-1 antibodies

Known as: BNabs, Broadly-neutralizing HIV-1 antibodies 
Broadly Neutralizing HIV-1 Antibodies (bNAbs) are neutralizing antibodies which neutralize multiple HIV-1 viral strains. In contrast, non-bNAbs are… (More)
Wikipedia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Treatment with broadly neutralizing antibodies (bNAbs) has proven effective against HIV-1 infections in humanized mice, non-human… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
Anti-retroviral drugs and antibodies limit HIV-1 infection by interfering with the viral life-cycle. In addition, antibodies also… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2016
Review
2016
Passive transfer of antibodies has long been considered a potential treatment modality for infectious diseases, including HIV… (More)
Is this relevant?
2015
2015
Treatment with broadly neutralizing antibodies (bNAbs) has recently proven effective against HIV-1 infections in humanized mice… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 4
Is this relevant?
2014
2014
The discovery of broadly neutralizing antibodies (bNAbs) has provided an enormous impetus to the HIV vaccine research and to… (More)
Is this relevant?
2012
2012
Background Recent efforts in HIV-1 vaccine design have focused on immunogens that evoke potent neutralizing antibody responses to… (More)
Is this relevant?
2012
2012
Background The isolation of broadly neutralizing HIV-1 antibodies that arise during infection has provided insights into the… (More)
Is this relevant?
2009
2009
Background A vaccine capable of stimulating protective anti-viral antibody responses is needed to curtail the global Acquired… (More)
Is this relevant?
Review
2006
Review
2006
The HIV-1 pandemic is a complex mix of diverse epidemics within and between countries and regions of the world, and is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2003
Review
2003
Ideally, a vaccine against human immunodeficiency virus type 1 (HIV-1) would induce neutralizing antibody levels which would… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?